Chugai Pharmaceutical Co....

OTC: CHGCY · Real-Time Price · USD
21.17
0.38 (1.83%)
At close: Aug 15, 2025, 12:30 PM

Chugai Pharmaceutical Income Statement

Financials in JPY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1,170.6B 1,111.4B 1,259.9B 999.76B
Cost of Revenue
339.41B 413.31B 476.25B 338.15B
Gross Profit
831.2B 698.06B 783.7B 661.61B
Operating Income
542B 439.17B 533.31B 421.9B
Interest Income
5M 4.65B 182M 166M
Pretax Income
543.03B 443.82B 531.17B 419.38B
Net Income
387.32B 325.47B 374.43B 303B
Selling & General & Admin
110.1B 112.58B 100.76B 102.42B
Research & Development
181.44B 174.87B 149.63B 137.3B
Other Expenses
-2.34B -28.56B -2.13B n/a
Operating Expenses
289.2B 258.89B 250.39B 239.72B
Interest Expense
-1.03B n/a 61M 48M
Selling & Marketing Expenses
110.1B 112.58B 77.15B 76.59B
Cost & Expenses
628.61B 672.19B 726.64B 577.86B
Income Tax Expense
155.72B 118.35B 156.74B 116.39B
Shares Outstanding (Basic)
3.29B 3.29B 3.29B 6.58B
Shares Outstanding (Diluted)
3.29B 3.29B 3.29B 6.58B
EPS (Basic)
117.70 98.90 113.82 46.06
EPS (Diluted)
117.68 98.90 113.79 46.04
EBITDA
542B 443.85B 531.23B 419.43B
EBIT
542B 443.85B 531.23B 419.43B
Depreciation & Amortization
n/a 4.67B 31.43B 30.87B